id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-E-0248-0006,FDA,FDA-2022-E-0248,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2025-05-27T04:00:00Z,2025,5,2025-05-27T04:00:00Z,,2025-05-27T22:17:54Z,,0,0,09000064863e62f8
FDA-2022-E-0248-0007,FDA,FDA-2022-E-0248,Letter to U.S. Patent and Trademark Office,Other,Letter(s),2025-05-27T04:00:00Z,2025,5,2025-05-27T04:00:00Z,,2025-05-27T22:18:16Z,,0,0,09000064b8dc1645